Clinical Trial Update: Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating rhTPO as a prophylactic treatment to prevent cancer treatment-induced thrombocytopenia in high-risk patients, focusing on effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Treatment-induced Thrombocytopenia

Drugs mentioned

• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: The First Affiliated Hospital of Dalian Medical University | Conditions: Cancer Treatment Induced Thrombocytopenia | Phase 4 | Status: UNKNOWN